Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. News
  7. All News
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about RESAPP HEALTH LIMITED
07/05RESAPP HEALTH : Commercial agreement with Doctors on Demand in Australia
PU
07/04Resapp Health Limited Signs A Commercial Agreement with Australian-Based Tele..
CI
06/03RESAPP HEALTH : Medgate extends European ResAppDx trial
PU
06/02Medgate Extends European ResAppDx Trial
CI
05/17RESAPP HEALTH : Recruits First Participant in COVID-19 Study; Shares Jump 6%
MT
05/16ResApp Health Limited Reports Recruited the First Participant in Its US-Based..
CI
05/04RESAPP HEALTH : Signs Distribution Deal for Smartphone Diagnostic App in Kenya; ..
MT
05/03RESAPP HEALTH : Agreement secured with Ilara Health to sell ResAppDx in Kenya
PU
05/03Agreement with Ilara Health to sell ResAppDx in Kenya
CI
04/12RESAPP HEALTH : Raises Over $4 Million in Placement
MT
04/11RESAPP HEALTH : secures firm commitments to raise $5.5 million
PU
03/24RESAPP HEALTH : Secures Regulatory Clearance in Australia for Wearable Medical D..
MT
03/24RESAPP HEALTH : TGA clearance achieved for wearable
PU
03/21RESAPP HEALTH LIMITED(ASX : RAP) dropped from S&P/ASX Emerging Companies Index
CI
03/21RESAPP HEALTH LIMITED(ASX : RAP) dropped from S&P/ASX All Ordinaries Index
CI
03/11RESAPP HEALTH : Grants AstraZeneca License for Cough Counting Tech for Asthma Pa..
MT
03/10RESAPP HEALTH : to Conduct Study to Develop Smartphone-Based COVID-19 Screening ..
MT
03/10ResApp to Progress Clinical Study to Develop Covid-19 Smartphone-Based Screen..
CI
03/04RESAPP HEALTH : Partner Begins Trial of ResAppDx in Switzerland
MT
03/03Medgate AG Commences ResApp Health Limited 's European ResAppDx Trial
CI
03/01RESAPP HEALTH : Secures CE Mark Certification for Wearable Device
MT
03/01Resapp Health Limited Achieves CE Mark for Wearable Device
CI
02/25ResApp Health Limited Provides an Update on its Two-Year, Non-Exclusive Softw..
CI
02/25ResApp Health Limited Announces Resignation of Stephen Hewitt-Dutton as Joint..
CI
02/24RESAPP HEALTH : Morgans rates RAP as Add
AQ
02/23Resapp Health Limited Reports Earnings Results for the Half Year Ended Decemb..
CI
02/09ResApp Health Limited Files Pre-Submission Package with the United States Foo..
CI
02/04RESAPP HEALTH : Receives R&D Tax Incentive Refund, Export Grant
MT
02/02RESAPP HEALTH : Receives European Patent for Cough Detection Technology; Shares ..
MT
02/01ResApp Health Limited Strengthens Patent Position in Europe
CI
01/10Resapp Health Limited Appoints Mike Connell as Vice President, Commercial
CI
2020Australian Shares Rise on Signing of US Pandemic Relief Bill; Queensland Reco..
MT
2020RESAPP HEALTH : Launches SleepCheck App on Some Android Devices; Shares Gain 8%
MT
2020ResApp Health Limited Launches SleepCheck
CI
2020RESAPP HEALTH : Cancels Partnership With RB; Shares Down 4%
MT
2020ResApp Terminates MOU with RB
CI
2020RESAPP HEALTH : Advances Development of ResAppDx Application
MT
2020ResApp Health Limited Releases Version 2.3 of its ResAppDx Smartphone Applica..
CI
2020ResApp Health Limited Appoints Stephen Hewitt-Dutton as Joint Company Secreta..
CI
2020RESAPP HEALTH : Expects US FDA Meeting to Make Way for Clearance of SleepCheck
MT
2020ResApp Health Limited Provides Update on the Company's Recent Meeting with th..
CI
2020RESAPP HEALTH : Respiratory Diagnosis Software to Integrate into a Holistic Tele..
MT
2020ResApp Health Limited Signs Non-Exclusive, Two-Year Software Licensing Agreem..
CI
2020RESAPP HEALTH : Partners With Medgate to Pilot ResAppDx for Telehealth Services ..
MT
2020Medgate to Pilot ResAppDx for Telehealth Across Europe
CI
2020ResApp Health Limited Launches ResAppDx on Select Android Devices
CI
2020AstraZeneca to Use New ResApp Software in Clinical Study
CI
2020ResApp Health Limited Partners with Healthcare Network
CI
2020ResApp Health Limited Files Pre-Submission Package with the United States Foo..
CI
2020Resapp Health Limited Reports Earnings Results for the Full Year Ended June 3..
CI
2020ResApp Health Limited Expands the Availability of SleepCheck to a Total of 36..
CI
2020ResAppDx-EU to be Launched on Phenix Health Pty Ltd.'s Telehealth App
CI
2020ResApp Health Limited and Coviu Global Pty Ltd Sign Service Agreement
CI
2020Ilara and ResApp Announce Evaluation of ResAppDx in Africa
CI
2020ResApp Health Limited Launches SleepCheck App for iPhone Now Available on the..
CI
2020RESAPP HEALTH LIMITED(ASX : RAP) added to S&P/ASX All Ordinaries Index
CI
2020ResApp Health Limited Signs MOU to Develop Respiratory App for Consumers
CI
2020Phenix Health Pty Ltd and ResApp Health Limited Signs Software Licensing Agre..
CI
2020ResApp Health Limited Announces German Health-Economic Evaluation and Update ..
CI
2020RESAPP HEALTH : Morgans rates RAP as Add
AQ
2020ResApp Appoints Michael Stein as Non-Executive Director
CI
2020ResApp Health Limited Announces SleepCheck, A Sleep Apnoea Screening App
CI
2020Coviu and ResApp Health Limited Complete Initial ResAppDx-EU Integration
CI
2020ResApp Health Limited Announces Resignation of Nathan Buzza as Non-Executive ..
CI
2020Resapp Provides an Update on Its Commercialization Activities in Europe, Incl..
CI
2020ResApp Health Limited and Phenix Health Pty Ltd Enter into Joint Development ..
CI
2020ResApp Health Limited Provides an Update on Its Direct-To-Consumer Product Be..
CI
2020ResApp Health Limited Provides Update on US Food and Drug Administration De N..
CI
2020Resapp Health Limited Reports Earnings Results for the Half Year Ended Decemb..
CI
2020ResApp Health Limited announced that it has received AUD 5 million in funding
CI
2020ResApp Health Limited announced that it expects to receive AUD 5 million in f..
CI
2020ResApp Receives Australian TGA Approval for Smartphone-Based Diagnostic Test ..
CI
2020ResApp Health Limited Successfully Completes Functional Testing of Both Handh..
CI
2019ResApp to Undertake a Clinical Study of COPD Screening in Indigenous Australi..
CI
2019ResApp and Coviu to Deploy ResAppDx-EU on Coviu's Telehealth Platform
CI
1  2  3  4Next
Upcoming event on RESAPP HEALTH LIMITED
Upcoming sector events